Search results
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
Zacks via Yahoo Finance· 13 hours agoAbbVie (ABBV) delivered earnings and revenue surprises of 2.21% and 2.65%, respectively, for the...
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 11 hours agoSales of the pharma giant's newer drugs are offsetting its Humira losses.
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 7 hours agoImage source: The Motley Fool. AbbVie (NYSE: ABBV) Q1 2024 Earnings Call Apr 26, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
Drugmaker AbbVie expects Humira volume erosion to worsen
Reuters via Yahoo News· 14 hours ago(Reuters) -AbbVie expects a drop in sales volumes of its blockbuster arthritis drug Humira to deepen...
AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That
Investor's Business Daily· 6 hours agoAbbVie is "firing on all cylinders," an analyst said Friday after the pharma giant beat Wall...
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
Motley Fool via Yahoo Finance· 6 hours agoBy almost any measure, AbbVie (NYSE: ABBV) shares should have risen Friday. The pharmaceutical giant...
AbbVie Raises Earnings Guidance Even as Humira Sales Continue to Drop
Barrons.com· 12 hours agoAbbVie raised its full-year earnings outlook despite continuing sales declines for autoimmune drug...
AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 11 hours agoWhile the top- and bottom-line numbers for AbbVie (ABBV) give a sense of how the business performed...
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
Zacks via Yahoo Finance· 10 hours agoAbbVie Inc. ABBV reported adjusted earnings of $2.31 per share for first-quarter 2024, beating the...
AbbVie Inc (ABBV) Q1 2024 Earnings: Adjusted EPS Tops Estimates Despite Revenue Challenges
GuruFocus.com via Yahoo Finance· 13 hours agoOn April 26, 2024, AbbVie Inc (NYSE:ABBV) released its 8-K filing, detailing the financial outcomes...